Independent Pharmacy Entity and Succession: The Owner-Pharmacist, the S Election, the LIFO Reserve, and the Buyer Who Wants the Prescription Files

Pharmacy owners decide their entity with the board of pharmacy's permit and a buyer's letter in view. The licensing layer: the state board of pharmacy issues the pharmacy's permit to the entity, requires a pharmacist-in-charge (a licensed pharmacist responsible for the pharmacy's operations — the owner-pharmacist, or an employed pharmacist where the owner isn't licensed; most states permit non-pharmacist ownership with a pharmacist-in-charge, though a few restrict it — North Dakota requires majority pharmacist ownership), and treats ownership changes as permit events (often a new permit, a new DEA registration, and new PBM and Medicare enrollments — a change of ownership disrupts the pharmacy's ability to bill the plans until the enrollments transfer, which is why pharmacy sales are timed and sequenced carefully). The liability floor: the dispensing error (the pharmacist's professional liability — the individual pharmacist remains liable for their own error), the controlled-substance regulatory exposure, the PBM audit recoupment, the premises, and the employment claims; the LLC or corporation separates the pharmacy's liabilities from the owner's personal assets, with professional liability, general liability, crime, and workers' compensation as the first line. The tax structures (the LLC cost guide): an S corporation (the standard for an independent pharmacy — the payroll exists: pharmacists, technicians, clerks); the owner-pharmacist's reasonable salary is the pharmacist market wage (a well-documented employed market — the state's workforce data and the chains' pay scales; US$120,000 to US$150,000 in most markets for a staff pharmacist, more for a pharmacist-in-charge) plus the owner's management component — a figure that consumes a large share of a small pharmacy's profit; the saving is payroll tax on the distribution portion (a pharmacist's US$120,000–US$150,000 salary sits below the US$184,500 wage base, so the distribution saves the rest of the base's 12.4 percent plus 2.9 percent Medicare — about US$8,200 a year at US$310,000 of profit with a US$150,000 salary). The specified service phase-out: pharmacy is in the health field (the regulations name pharmacists) — the QBI deduction phases out above the taxable-income range and is zero once taxable income passes its top (US$276,750 single, US$553,500 joint in 2026); the retirement plan (a safe-harbor 401(k) and, for an owner with age and income, a cash balance plan — the dental entity guide's instrument) is the planning tool, and for an owner in the range the plan pulls taxable income toward the threshold. The LIFO reserve and the entity: a pharmacy on LIFO (the independent pharmacy taxes guide) carries a reserve — the deferred tax on years of inventory inflation — that comes back into income when the inventory is liquidated or the business is sold in an asset sale (the buyer purchases the inventory at current value; the seller's LIFO reserve is ordinary income in the sale year); a C corporation converting to S status must recapture its LIFO reserve (section 1363(d) — the LIFO reserve included in the C corporation's income for its last year before the election, with the resulting tax payable in four equal annual installments) — so an old pharmacy corporation's conversion to S status carries a LIFO cost that is computed before the election; a stock sale transfers the LIFO layers to the buyer (who inherits the deferred tax — priced in the deal). The real estate: a pharmacy that owns its building holds it in a separate real estate LLC leasing to the pharmacy (the auto repair entity guide's structure) — common among long-established independents, and valuable at exit (a chain buying the prescription files doesn't want the building; a pharmacist-buyer may lease it). The exits. The chain file buy: the national and regional chains buy independent pharmacies' prescription files (the patient records and the refill relationships) — often closing the independent's location and transferring the patients to the chain's nearby store — paying a price per prescription or a multiple of the files' gross margin; for tax purposes, the seller's asset sale allocates the price to the customer lists and goodwill (capital gain — with any personal goodwill of the owner-pharmacist sold directly — the consulting succession guide), the inventory (ordinary income, including the LIFO reserve's recapture), the equipment (recapture), and a non-compete (ordinary income to the seller, a fifteen-year intangible to the buyer — the section 197 guide); the S corporation's asset sale is single-taxed. The pharmacist-buyer: an employed pharmacist (often the pharmacist-in-charge) buys the pharmacy over time — financed by an SBA loan, a seller note, and the pharmacy's cash flow — keeping the location open; the purchase-price allocation and the LIFO treatment are negotiated (the buyer who buys stock inherits the LIFO layers; the buyer who buys assets gets a stepped-up inventory basis and the seller recaptures). The next generation: a child who is a pharmacist inherits or buys the pharmacy — the family funeral home's gifting and sale path (the funeral home entity guide), with the pharmacist-in-charge requirement met by the child's license. Estimated taxes: a pharmacy's revenue is steady across the year (prescriptions refill monthly; the flu season's immunizations add a fall bump; the cold and allergy seasons lift the front store), with the PBM payment cycles lagging adjudication by one to four weeks and the clawbacks arriving by the PBM's schedule; the S corporation owner's salary withholding through the pharmacy's biweekly payroll covers the tax on salary and projected distributions — deemed paid evenly across the year — with the fall recompute adjusting the December payroll for the year's actual gross margin (which moves with the reimbursement rates and the drug costs), the LIFO computation's expected effect (a large inflation year increases cost of goods sold under LIFO — projected in the fall from the index), the equipment placed in service, the retirement plan contribution (sized in the fall), and any PBM clawbacks or recoupments withheld. The failure modes: the year-end LIFO effect unprojected; the retirement contribution decided in April rather than sized in the fall; the reimbursement cuts that hit the margin mid-year not reflected in the withholding; and a sale's LIFO recapture unplanned. The annual re-run: profit, the owner's salary against the pharmacist market, the retirement plan, the LIFO reserve's size, the permits and enrollments, and the exit horizon — revisited each January.

Key takeaways

• The board of pharmacy permits the entity and requires a pharmacist-in-charge; ownership changes are permit, DEA, and enrollment events that interrupt billing until they transfer.
• The owner-pharmacist's salary is the pharmacist market wage plus management — a large share of a small pharmacy's profit; the payroll-tax saving is modest — about US$8,200 a year at US$310,000 of profit.
• Pharmacy is a specified service trade — the QBI deduction is zero above the range; the retirement plan is the instrument.
• The LIFO reserve is a deferred tax: recaptured in an asset sale's inventory allocation, inherited by a stock buyer, and recaptured on a C-to-S conversion (payable over four years) — computed before the election or the sale.
• Exits: the chain file buy (an asset sale — customer lists and goodwill at capital gain, inventory and LIFO at ordinary, the non-compete as ordinary), the pharmacist-buyer, or the next generation; the building in a separate LLC stays with the family.
• Estimated taxes run through the pharmacy's payroll, recomputed in the fall for the margin, the LIFO effect, equipment, and the retirement contribution.

The independent pharmacy's entity and succession worksheet

Permit, pharmacist-in-charge, DEA, and enrollments in the entity. Coverage (professional, GL, crime, workers' comp). S corporation; pharmacist-market salary plus management. QBI (zero above the range); retirement plan design and fall sizing. LIFO reserve; conversion recapture if a C corporation; sale treatment by structure. Real estate LLC. Exit: chain file buy, pharmacist-buyer, or next generation; allocation; change-of-ownership sequencing. Estimated taxes through payroll; fall recompute. Fifteen minutes each January, with the LIFO reserve and the enrollments alongside.

Worked example

The pharmacy from the taxes guide: an S corporation (converted from its founder's 1988 C corporation eleven years ago — before its LIFO election six years ago, so there was no reserve to recapture), owned by a pharmacist, 61, paid US$150,000 as pharmacist-in-charge plus management, with a US$160,000 distribution, the QBI deduction zero above the range (she files single, and with the building's rent her taxable income is past the US$276,750 top of the phase-in), and a safe-harbor 401(k) with a cash balance plan adding US$180,000 of deductible contributions (sized each October); the building in her real estate LLC. Two offers: a chain's offer for the prescription files at a price per prescription (the store would close; the patients transfer to the chain two miles away) — an asset sale allocating the price to the files and goodwill (capital gain), the inventory at its current value (ordinary income including the US$186,000 LIFO reserve's recapture), the equipment (recapture), and a three-year non-compete (ordinary); and her pharmacist-in-charge's offer to buy the pharmacy as a going concern with an SBA loan and a seller note — structured as an asset purchase with a stepped-up inventory basis for the buyer and the same LIFO recapture for the seller, the building leased to him from her LLC for fifteen years, and a transition period in which the permit, the DEA registration, and eleven PBM enrollments transfer in a sequenced change of ownership. She chooses the pharmacist-buyer: a lower price, but the rent, the community's pharmacy, and a buyer she trained. A founder across the state who had never converted his C corporation faced a double tax on the chain's asset purchase — the corporation's gain and then the liquidating distribution — on a sale the S election would have taxed once.

Official sources

Publication 538 states: “File Form 970, Application To Use LIFO Inventory Method, or a statement with all the information required on Form 970 to adopt the LIFO method. You must file the form (or the statement) with your timely filed tax return for the year in which you first use LIFO.” — Internal Revenue Service, Publication 538, Accounting Periods and Methods, https://www.irs.gov/publications/p538

The IRS states: “S corporations must pay reasonable compensation to a shareholder-employee in return for services that the employee provides to the corporation before non-wage distributions may be made to the shareholder-employee.” — Internal Revenue Service, S corporation compensation and medical insurance issues, https://www.irs.gov/businesses/small-businesses-self-employed/s-corporation-compensation-and-medical-insurance-issues

Practitioner note

An independent pharmacy's entity planning is exit planning with a LIFO reserve in the middle of it: years of inflation deferred on the shelf come back as ordinary income in an asset sale's inventory allocation, pass to a stock buyer as a deferred tax, and were recaptured over four years on any C-to-S conversion. Our pharmacy worksheets set the owner-pharmacist's salary at the pharmacist market, size the cash balance plan each October because pharmacy is health and the QBI deduction is zero above the range, keep the building in a separate LLC, and sequence the permit, DEA, and PBM enrollment transfers — because a change of ownership that interrupts billing costs more than any allocation decision.

See also: For related guidance, see veterinary practice entity structure and the consolidator that buys the assets; and browse every small business tax guide, by situation.

Next step

Fairlight Accounting is a cross-border accounting and tax practice with a U.S. Tax Desk and a Canadian Tax Desk. Our U.S. Tax Desk handles independent pharmacy entity and succession planning — board of pharmacy permit and pharmacist-in-charge coordination, the S election with pharmacist-market compensation, retirement plan design, LIFO reserve analysis for conversions and sales, real estate LLC structuring, and chain file buy or pharmacist-buyer exit structuring. See pricing or book a call.